Welcome to CDC stacks | Diagnosing an Infection Control Risk - 50548 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Diagnosing an Infection Control Risk
Filetype[PDF-36.35 KB]


Details:
No Related Documents.
You May Also Like:
  1. A clinical prediction rule for diagnosing human infections with avian influenza A(H7N9) in a hospital emergency department setting
    Personal Author:
    Liao, Qiaohong; Ip, Dennis K M; Tsang, Tim K; Cao, Bin; Jiang, Hui; Liu, Fengfeng; Zheng, Jiandong; Peng, Zhibin; Wu, Peng; Huai, Yang; Lau, Eric H Y; Feng, Luzhao; Leung, Gabriel M; Yu, Hongjie; Cowling, Benjamin J;
    Published:
    Aug 05 2014
    Source:
    BMC Med. 12(1).
    Description:
    Background : Human infections with avian influenza A(H7N9) virus are associated with severe illness and high mortality. To better inform triage decisions of hospitalization and management, we developed a clinical prediction rule for diagnosing patien...
    File Type:
    Filetype[PDF - 272.71 KB]
  2. Barriers to Creutzfeldt-Jakob Disease Autopsies, California
    Personal Author:
    Louie, Janice K.; Gavali, Shilpa S.; Belay, Ermias D.; Trevejo, Rosalie; Hammond, Lucinda H.; Schonberger, Lawrence B.; Vugia, Duc J.;
    Published:
    Sep 2004
    Source:
    Emerg Infect Dis. 10(9):1677-1680.
    Description:
    Creutzfeldt-Jakob disease (CJD) surveillance relies on autopsy and neuropathologic evaluation. The 1990-2000 CJD autopsy rate in California was 21%. Most neurologists were comfortable diagnosing CJD (83%), but few pathologists felt comfortable diagno...
    File Type:
    Filetype[PDF - 160.13 KB]
  3. Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus
    Personal Author:
    Mazurek, Gerald H.; McDougal, J. Steven; Nicholson, Janet K. A., 1948-; Villarino, Margarita E.;
    Corporate Author:
    National Center for HIV, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.. Centers for Disease Control and Preventiom (U.S.). National Center for Infectious Diseases (U.S.). National Center for Infectious Diseases (U.S.), Division of AIDS, STD, and TB Laboratory Research..
    Published:
    January 31, 2003
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 52, no. RR-2
    Description:
    These guidelines were developed by CDC for laboratorians who perform immunophenotyping for detection and enumeration of CD4+ T-cells and other lymphocyte subsets in persons infected with human immunodeficiency virus (HIV). The guidelines describe sin...
    Status:
    current
    File Type:
    Filetype[PDF - 397.77 KB]
  4. Old and new approaches to diagnosing and treating latent tuberculosis in children in low-incidence countries
    Personal Author:
    Cruz, Andrea T.; Starke, Jeffrey R.; Lobato, Mark N.;
    Published:
    Feb 2014
    Source:
    Curr Opin Pediatr. 26(1):106-113.
    Description:
    Purpose of review : The primary purpose is to review guidance on the testing and treatment of latent tuberculosis infection (LTBI) in children. Most children and adults with LTBI have positive tuberculin skin test (TST) or interferon gamma release as...
    File Type:
    Filetype[PDF - 123.82 KB]
  5. Interferon-gamma release assays (IGRAs) - blood tests for TB infection
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published:
    November, 2011
    Description:
    Interferon-Gamma Release Assays (IGRAs) are whole-blood tests that can aid in diagnosing Mycobacterium tuberculosis infection. They do not help differentiate latent tuberculosis infection (LTBI) from tuberculosis disease. Two IGRAs that have been app...
    File Type:
    Filetype[PDF - 179.62 KB]